Tu2049 Long term Outcomes of PerOral Endoscopic Myotomy (POEM) in Achalasia patients With a minimum follow-up of 2 years: A multicenter study

2016 ◽  
Vol 83 (5) ◽  
pp. AB628 ◽  
Author(s):  
Saowanee Ngamruengphong ◽  
Haruhiro Inoue ◽  
Amol Bapaye ◽  
Michael Ujiki ◽  
Lava Y. Patel ◽  
...  
Endoscopy ◽  
2020 ◽  
Author(s):  
Olivier Ragi ◽  
Jérémie Jacques ◽  
Julien Branche ◽  
Sarah Leblanc ◽  
Geoffroy Vanbiervliet ◽  
...  

Abstract Background: Data on the long-term outcomes of gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis are lacking. We report the results of a large multicenter long-term follow-up study of G-POEM for refractory gastroparesis. Methods: This was a retrospective multicenter study of all G-POEM operations performed in seven expert French centers for refractory gastroparesis with at least 1 year of follow-up. The primary endpoint was the 1-year clinical success rate, defined as at least a 1-point improvement in the Gastroparesis Cardinal Symptom Index (GCSI). Results: 76 patients were included (60.5 % women; age 56 years). The median symptom duration was 48 months. The median gastric retention at 4 hours (H4) before G-POEM was 45 % (interquartile range [IQR] 29 % – 67 %). The median GCSI before G-POEM was 3.6 (IQR 2.8 – 4.0). Clinical success was achieved in 65.8 % of the patients at 1 year, with a median rate of reduction in the GCSI score of 41 %. In logistic regression analysis, only a high preoperative GCSI satiety subscale score was predictive of clinical success (odds ratio [OR] 3.41, 95 % confidence interval [CI] 1.01 – 11.54; P = 0.048), while a high rate of gastric retention at H4 was significantly associated with clinical failure (OR 0.97, 95 %CI 0.95 – 1.00; P = 0.03). Conclusions: The results confirm the efficacy of G-POEM for the treatment of refractory gastroparesis, as evidenced by a 65.8 % clinical success rate at 1 year. Although G-POEM is promising, prospective sham-controlled trials are urgently needed to confirm its efficacy and identify the patient populations who will benefit most from this procedure.


2020 ◽  
Vol 133 (8) ◽  
pp. 996-998
Author(s):  
Wen-Gang Zhang ◽  
Ning-Li Chai ◽  
Ya-Qi Zhai ◽  
En-Qiang Linghu ◽  
Hui-Kai Li

2019 ◽  
Vol 89 (6) ◽  
pp. AB82-AB83
Author(s):  
Jad P. AbiMansour ◽  
Hitomi Minami ◽  
Pietro Familiari ◽  
Rosario Landi ◽  
Guido Costamagna ◽  
...  

2018 ◽  
Vol 87 (6) ◽  
pp. AB564-AB565
Author(s):  
Olaya I. Brewer Gutierrez ◽  
Pietro Familiari ◽  
Guido Costamagna ◽  
Stefan Seewald ◽  
Shivangi Dorwat ◽  
...  

2017 ◽  
Vol 85 (5) ◽  
pp. AB581
Author(s):  
Stavros N. Stavropoulos ◽  
Xiaocen Zhang ◽  
Rani J. Modayil ◽  
Krishna C. Gurram ◽  
Collin E. Brathwaite ◽  
...  

2018 ◽  
Vol 64 (3) ◽  
pp. 803-810 ◽  
Author(s):  
Chenghai He ◽  
Meng Li ◽  
Bin Lu ◽  
Xiao Ying ◽  
Chen Gao ◽  
...  

2018 ◽  
Vol 147 ◽  
Author(s):  
D. M. Berendes ◽  
C. E. O'Reilly ◽  
S. Kim ◽  
R. Omore ◽  
J. B. Ochieng ◽  
...  

AbstractGiven the challenges in accurately identifying unexposed controls in case–control studies of diarrhoea, we examined diarrhoea incidence, subclinical enteric infections and growth stunting within a reference population in the Global Enteric Multicenter Study, Kenya site. Within ‘control’ children (0–59 months old without diarrhoea in the 7 days before enrolment,n= 2384), we examined surveys at enrolment and 60-day follow-up, stool at enrolment and a 14-day post-enrolment memory aid for diarrhoea incidence. At enrolment, 19% of controls had ⩾1 enteric pathogen associated with moderate-to-severe diarrhoea (‘MSD pathogens’) in stool; following enrolment, many reported diarrhoea (27% in 7 days, 39% in 14 days). Controls with and without reported diarrhoea had similar carriage of MSD pathogens at enrolment; however, controls reporting diarrhoea were more likely to report visiting a health facility for diarrhoea (27%vs.7%) or fever (23%vs.16%) at follow-up than controls without diarrhoea. Odds of stunting differed by both MSD and ‘any’ (including non-MSD pathogens) enteric pathogen carriage, but not diarrhoea, suggesting control classification may warrant modification when assessing long-term outcomes. High diarrhoea incidence following enrolment and prevalent carriage of enteric pathogens have implications for sequelae associated with subclinical enteric infections and for design and interpretation of case–control studies examining diarrhoea.


Sign in / Sign up

Export Citation Format

Share Document